SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Surgalign Holdings, Inc. (SRGA) .
本页证实的标准:
- VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+1813.6%).
- 分析师共识目标价 $3.50 (+1813.6% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 49/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — SRGA
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.01
EV/EBITDA0.0
每股数据
EPS (TTM)$-8.33
每股账面价值$0.00
每股营收$12.51
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$3.50 (+1813.6%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2013 |
$-0.32 |
$197.98M |
$-17.81M |
-9% |
| 2014 |
$0.05 |
$262.81M |
$2.7M |
1% |
| 2015 |
$0.25 |
$282.29M |
$14.92M |
5.3% |
| 2016 |
$-0.25 |
$272.87M |
$-14.4M |
-5.3% |
| 2017 |
$0.10 |
$279.56M |
$6.27M |
2.2% |
| 2018 |
$-0.02 |
$280.86M |
$-1.25M |
-0.4% |
| 2019 |
$-106.39 |
$117.42M |
$-248.78M |
-211.9% |
| 2020 |
$-78.30 |
$101.75M |
$-194.2M |
-190.9% |
| 2021 |
$-30.08 |
$90.5M |
$-122.91M |
-135.8% |
| 2022 |
$-8.33 |
$81.98M |
$-54.61M |
-66.6% |
